Eli Lilly Corp. buy SVB Leerink LLC
Start price
27.04.26
/
50%
€758.50
Target price
27.04.27
€902.26
Performance (%)
39.70%
Price
18.08.26
€1,059.6
Summary
This prediction is currently active. With a performance of 39.70% the BUY prediction by SVB_Leerink_LLC is a big success. This prediction currently runs until 27.04.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 0.703% | 0.703% |
| iShares Core DAX® | -0,05 % | 5,96 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % |
| iShares S&P 500 | -0,36 % | 2,75 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (LLY) had its price target lowered by Leerink Partners from $1,296.00 to $1,058.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€920.00
07.02.26
07.02.26
€1,097.5
07.02.27
07.02.27
15.17%
18.08.26
18.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€807.50
10.11.25
10.11.25
€955.18
10.11.26
10.11.26
31.22%
18.08.26
18.08.26